Quadrant Capital Group LLC Arvinas, Inc. Transaction History
Quadrant Capital Group LLC
- $1.42 Billion
- Q3 2024
A detailed history of Quadrant Capital Group LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 135 shares of ARVN stock, worth $2,524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135
Previous 135
-0.0%
Holding current value
$2,524
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARVN
# of Institutions
228Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$131 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$126 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$117 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$72.1 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$52 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $995M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...